皓元医药(688131) - 民生证券股份有限公司关于上海皓元医药股份有限公司2025年半年度持续督导跟踪报告

2025 2024 12 19 2024 12 19 2026 12 31 2025 1-6 | 1 | | --- | | 2 | | 3 | | 4 | | 5 | | --- | | 6 | | 7 | | 8 | | 9 | | 10 | | 11 | | 12 | | 13 | | --- | | 14 | | 15 | | 16 | | 50% | 21 1 234 14.7 CDMO 33,219.50 20.24% 6,147.09 5,674.58 2024 28.15% 1 2025 | 2025 1-6 | 2024 1-6 | | | --- | --- | --- | | | | % | | 131,094.28 | 105,554.91 | 24.20 | | 15,176.15 | 7,040.77 | 115.55 | | 14,057.11 | 6,649.58 | 111.40 | | -1,043.09 | 7,709.98 | -113.53 | | 2025-6-30 | 2024-12-31 | | | | | % | | 302,310.91 | 287,787. ...